Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Acute Pulmonary Dysfunction After Stem Cell Transplant
NCT00029328Phase 2Completed
- Sponsor
- Food and Drug Administration
- Start
- Sep 2001
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in Idiopathic Pneumonia Syndrome (IPS), not applicable; "lung injury" is not a specific disease, sponsored by Food and Drug Administration. Started Sep 2001; status: completed.
02
Drugs
etanercept
03
Conditions
Idiopathic Pneumonia Syndrome (IPS)not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on NCT00029328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00029328.